Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

FGFR1 rearrangement + Chr t(8;13)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

FGFR1 rearrangement + Chr t(8;13)	T Acute Lymphoblastic Leukemia	FGFR1 rearrangement + Chr t(8;13)	T Acute Lymphoblastic Leukemia	Tyrosine kinase inhibitor Resistant: C4 – Case Studies Tyrosine kinase inhibitor Resistant : C4	Tyrosine kinase inhibitor Resistant: C4 – Case Studies Tyrosine kinase inhibitor Resistant : C4
FGFR1 rearrangement + Chr t(8;13)	Lymphoma	FGFR1 rearrangement + Chr t(8;13)	Lymphoma	pemigatinib Sensitive: C4 – Case Studies pemigatinib Sensitive : C4	pemigatinib Sensitive: C4 – Case Studies pemigatinib Sensitive : C4
FGFR1 rearrangement + Chr t(8;13)	Lymphoma	FGFR1 rearrangement + Chr t(8;13)	Lymphoma	Tyrosine kinase inhibitor Resistant: C4 – Case Studies Tyrosine kinase inhibitor Resistant : C4	Tyrosine kinase inhibitor Resistant: C4 – Case Studies Tyrosine kinase inhibitor Resistant : C4